MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Engage in Healthy Eating: A Community-Guided Approach to Culturally Sensitive Nutrition Support for People with Parkinson’s Disease (PD)

    H. Shah, R. Gilbert, P. Purdy, L. Quinn, A. Parker, E. Adelman, A. Shiell, R. Pena, S. Lim (New York, USA)

    Objective: To co-develop a culturally affirming, family-centered Healthy Eating Program with community members for managing PD symptoms and achieving personal wellness goals. Background: Growing evidence…
  • 2026 International Congress

    Global Trends in Parkinson’s Disease Research: A Bibliometric Snapshot (2021–2024)

    R. Mansour, F. Namnom, A. Ali, I. Hanafi (Latakia, Syrian Arab Republic)

    Objective: To characterize geographical patterns in scholarly output on Parkinson's Disease (PD) from 2021 to 2024. Background: The burden of PD shows substantial geographic variation…
  • 2026 International Congress

    Videonystagmography findings, Postural Balance, and Falls in Parkinson’s disease patients

    I. Monteiro, M. Salmito, B. Fernandes, D. Camelo, F. Rolim, A. Ferreira Gomes, AS. Lima Verde, C. Figueiredo, F. Carvalho (Fortaleza, Brazil)

    Objective: To characterize the clinical profile related to oculomotor control, balance, motor severity, and frequency of fall in individuals with PD Background: Extraocular motility is…
  • 2026 International Congress

    Non-Motor Outcomes of Unilateral Magnetic Resonance-Guided Focused Ultrasound Surgery in Parkinson’s Disease: A Meta-Analysis

    W. Kashif, K. Aung, S. Lane, T. Gilbertson, S. Khan, J. Osman-Farah, A. Macerollo (Liverpool, United Kingdom)

    Objective: This study aimed to assess the efficacy of the procedure specifically in relation to non-motor outcomes such as quality of life, disability scores, effect…
  • 2026 International Congress

    Experiences of Patients with Parkinson’s Disease regarding Pharmacological Treatment in three Peruvian Regions

    J. Moya-Salazar, B. Cañari, A. Sobrino (Chiclayo, Peru)

    Objective: To explore the experiences of patients with Parkinson's disease (PD) regarding pharmacological treatment in three Peruvian regions with diverse geographic and cultural contexts. Background:…
  • 2026 International Congress

    The Effect of Levodopa on Calpain Activity in Patients with Parkinson’s Disease

    Z. Muruzheva, M. Karpenko (St. Petersburg, Russian Federation)

    Objective: The objective of this report is to investigate the effect of Levodopa therapy on calpain activity in patients with advanced stages of Parkinson's disease to…
  • 2026 International Congress

    Dual-Task Cost Assessment in Parkinson’s Disease: A Literature Review of Clinical Applications and Measurement Approaches

    C. Balasubramanian, Z. Board, J. Thomas, H. Malik, S. Bagdadi, I. Khan, K. Mangipudi (Jacksonville, USA)

    Objective: This literature review examines current evidence on dual-task cost assessment in PD, focusing on measurement approaches, clinical relevance, and factors influencing performance. Background: Parkinson’s…
  • 2026 International Congress

    Parkinson’s Disease Early Diagnostic and Prognostic Biomarkers Identified by Large-scale Plasma and Cerebrospinal Fluid Proteomic Profiling

    XY. Li, YL. Tang, J. Wang (Shanghai, China)

    Objective: To identify reliable diagnostic and prognostic protein biomarkers for early-stage Parkinson’s disease (PD) using large-scale proteomic profiling of plasma and cerebrospinal fluid (CSF).To identify…
  • 2026 International Congress

    The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the pharmacological and methodological factors underlying the "GLP-1 paradox" by comparing the outcomes of lixisenatide and exenatide, with an emphasis on kinetics,…
  • 2026 International Congress

    Clustered Difference of Gut Microbiome in Helicobacter pylori-negative and positive Group Effect on Clinical Motor Symptoms in PD (Helicobacter pylori-Stool Microbiome or HP-SM Trial)

    W. Wongpipathpong, N. Srivanitchapoom, M. Utharntharm, P. Pongchaikul, N. Tungtrongchitr (Samut Prakan, Thailand)

    Objective: This study aims to evaluate the therapeutic effect of H.pylori eradication on clinical motor symptoms in PD and the association between gut microbiomes. Background: Previous…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley